These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 5316955)

  • 1. Inactivation of isoniazid by condensation in a syrup preparation.
    Rao KV; Kailasam S; Menon NK; Radhakrishna S
    Bull World Health Organ; 1971; 45(5):625-32. PubMed ID: 5316955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of isoniazid by condensation in a syrup preparation.
    Rao KV; Kailasam S; Menon NK; Radhakrishna S
    Indian J Med Res; 1971 Sep; 59(9):1343-53. PubMed ID: 5161562
    [No Abstract]   [Full Text] [Related]  

  • 3. [Determination of the degree of inactivation of preparations of isonicotinic acid hydrazides in tuberculous patients].
    Shefer LB
    Lab Delo; 1966; 5():298-301. PubMed ID: 4168957
    [No Abstract]   [Full Text] [Related]  

  • 4. Inactivation of isoniazid (INH) in Swedish tuberculous patients before and during treatment with para-aminosalicylic acid (PAS).
    Hanngren A; Borgå O; Sjöqvist F
    Scand J Respir Dis; 1970; 51(1):61-9. PubMed ID: 5456864
    [No Abstract]   [Full Text] [Related]  

  • 5. Isoniazid acetylation rates (phenotypes) of patients being treated for tuberculosis.
    Mason E; Russell DW
    Bull World Health Organ; 1971; 45(5):617-24. PubMed ID: 5316954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [On the problem of the inactivation of antibacterial drugs and drug resistance of disease agents].
    Rudoĭ NM; Lubenson AS
    Biull Eksp Biol Med; 1969 Feb; 67(2):43-5. PubMed ID: 4980639
    [No Abstract]   [Full Text] [Related]  

  • 7. [Demonstration of a correlation between the degree of pigmentation and the power of inactivation of isoniazid in man].
    Vivien JN; Leperchey F; Vicaut E; Deplus S; Gervais P
    Rev Mal Respir; 1987; 4(4):173-6. PubMed ID: 3671864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethambutol syrup in combination with isoniazid in the treatment of childhood tuberculosis.
    Rahaju N; Rahaju NN; Widya M; Sutedjo
    Paediatr Indones; 1972 May; 12(5):213-20. PubMed ID: 4539649
    [No Abstract]   [Full Text] [Related]  

  • 9. [The importance of estimating the individual acetylation rate in modern tuberculosis treatment].
    Duru S
    Mikrobiyol Bul; 1979 Jan; 13(1):53-61. PubMed ID: 555792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Importance of the inactivation of tubazid in the complex therapy of patients with pulmonary tuberculosis].
    Kartseva TM
    Probl Tuberk; 1970; 48(4):36-9. PubMed ID: 4990498
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of dose formulation on isoniazid absorption in two young children.
    Notterman DA; Nardi M; Saslow JG
    Pediatrics; 1986 Jun; 77(6):850-2. PubMed ID: 3086830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New aspects of the effect of isoniazid on transaminase activity in tuberculosis].
    Sodikov ES; Kazakov KS
    Vopr Med Khim; 1978; 24(1):3-7. PubMed ID: 664479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Thiamine metabolism in children with tuberculosis during therapy with streptomycin, phthivazid and PAS].
    Nazarenko GG
    Pediatriia; 1968 Jan; 47(1):80-4. PubMed ID: 5754014
    [No Abstract]   [Full Text] [Related]  

  • 14. Free sugar concentration and pH of paediatric medicines in Brazil.
    Pierro VS; Abdelnur JP; Maia LC; Trugo LC
    Community Dent Health; 2005 Sep; 22(3):180-3. PubMed ID: 16161883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetic studies of the interaction between isoniazid and reducing sugars.
    Devani MB; Shishoo CJ; Doshi KJ; Patel HB
    J Pharm Sci; 1985 Apr; 74(4):427-32. PubMed ID: 3999004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability of phenylpropanolamine hydrochloride in liquid formulations containing sugars.
    Barry RH; Weiss M; Johnson JB; DeRitter E
    J Pharm Sci; 1982 Jan; 71(1):116-8. PubMed ID: 7057363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Compounding of pure tablets of isoniazid with prolonged action].
    Seleznev EF; Korobkov ES; Griniuk IL
    Farmatsiia; 1978; 27(4):24-6. PubMed ID: 357190
    [No Abstract]   [Full Text] [Related]  

  • 18. The bioavailability of isoniazid, rifampin, and pyrazinamide in two commercially available combined formulations designed for use in the short-course treatment of tuberculosis.
    Ellard GA; Ellard DR; Allen BW; Girling DJ; Nunn AJ; Teo SK; Tan TH; Ng HK; Chan SL
    Am Rev Respir Dis; 1986 Jun; 133(6):1076-80. PubMed ID: 3717760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative value of tubazid, larusan and preparation INKh-17].
    Smirnov GA; Efremova ZR; Galkeeva TN
    Probl Tuberk; 1970; 48(4):29-36. PubMed ID: 5471127
    [No Abstract]   [Full Text] [Related]  

  • 20. [On the metabolism of isoniazid in the body: the problem of rapid inactivation].
    Vivenzio L
    Arch Tisiol Mal Appar Respir; 1967 Jul; 22(7):637-67. PubMed ID: 5302254
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.